NCT05274009

Brief Summary

With the increasing incidence and severity of extreme heat events accompanying climate change, there is an urgent need for sustainable cooling strategies to protect heat-vulnerable older adults, who are at increased risk of adverse health events during heat stress. Health agencies including the World Health Organization, the United States Centers for Disease Control and Prevention, and Health Canada currently recommend visiting a cooling centre or other air-conditioned location for 1-3 hours per day during extreme heat events to mitigate hyperthermia and strain on the cardiovascular system and therefore the risk adverse health events. However, our recent trial shows that while brief air-conditioning exposure is effective for reducing body temperature and cardiovascular burden in healthy older adults, the physiological impacts of cooling abate quickly following return to the heat. The purpose of this project is therefore to assess whether shorter but more frequent air-conditioning exposure provides more effective cooling than current recommendations (a single 1-3-hour cooling bout) in older adults with or without common chronic health conditions associated with increased vulnerability to extreme heat. This will be accomplished by evaluating physiological strain in older adults with and without diabetes and/or hypertension exposed for 8 hours to conditions reflective of extreme heat events in temperate, continental climates (35°C, 60% relative humidity). Participants will complete 3 separate simulated heat event exposures: i) a control trial (no cooling throughout the 8-hour heat event); ii) a recommended cooling trial (3 hours of heat exposure followed by 2 hours cooling); and iii) a hybrid cooling trial (2 hours of heat exposure followed by 1 hour cooling, another 2 hours heat exposure followed by 1 hour cooling, and a final 2-hour heat exposure).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 10, 2022

Completed
1.1 years until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

October 21, 2022

Status Verified

October 1, 2022

Enrollment Period

1 year

First QC Date

February 25, 2022

Last Update Submit

October 19, 2022

Conditions

Keywords

Heat waveCooling centerHeat strainCardiovascular strainHeat and health protectionExtreme heat eventsThermal comfort

Outcome Measures

Primary Outcomes (2)

  • Core temperature (peak)

    Peak rectal temperature measured during the 8-hour heat exposure.

    8-hour heat exposure

  • Core temperature (AUC)

    Rectal temperature will be measured continuously throughout each exposure and the area under the curve will be calculated.

    8-hour heat exposure

Secondary Outcomes (12)

  • Heart rate temperature (peak)

    8-hour heat exposure

  • Heart rate (AUC)

    8-hour heat exposure

  • Mean skin temperature

    Before and continuously throughout each 8 hour exposure

  • Arterial blood pressures

    Every hour during the 8-hour heat exposure

  • SDNN

    Every hour during the 8-hour heat exposure

  • +7 more secondary outcomes

Study Arms (3)

Extreme heat event simulation + no cooling (control)

EXPERIMENTAL

Adults aged 60-85 years with or without type 2 diabetes and/or hypertension

Other: No cooling (control)

Extreme heat event simulation + recommended cooling

EXPERIMENTAL

Adults aged 60-85 years with or without type 2 diabetes and/or hypertension

Other: Recommended cooling

Extreme heat event simulation + hybrid cooling

EXPERIMENTAL

Adults aged 60-85 years with or without type 2 diabetes and/or hypertension

Other: Hybrid cooling

Interventions

Participants are exposed to 35°C, 60% relative humidity for 8 hours.

Extreme heat event simulation + no cooling (control)

Participants are exposed to 35°C, 60% relative humidity for 3 hours, are then moved to an air-conditioned room for 2 hours (\~23°C, \~50% relative humidity), and then return to the heat for a final 3 hours.

Extreme heat event simulation + recommended cooling

Participants are exposed to 35°C, 60% relative humidity for 2 hours, are moved to an air-conditioned room for 1 hour (\~23°C, \~50% relative humidity), return to the heat for 2 hours, move back to the air-conditioned room for 1 hour, and then return to the heat for a final 2 hours

Extreme heat event simulation + hybrid cooling

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult aged 60-85 years
  • Male or female
  • Body mass index \< 35 kg/m2
  • For participants with type 2 diabetes: at least one year lapsed since diagnosis and hemoglobin A1c 6.0-10.5%.
  • For participants with hypertension: at least one year lapsed since diagnosis or average resting blood pressure \>140 systolic or \>90 diastolic

You may not qualify if:

  • Currently smoking or quit \<5 years ago
  • Moderate or serious medical conditions (other than Type 2 diabetes or high blood pressure), particularly those known to influence physiological responses to heat exposure (e.g., diagnosed heart disease, neurological disorders)
  • Heat adapted due to repeated exposure to hot environments (use sauna, recent travel to hot climates, other)
  • For participants with type 2 diabetes: "Brittle" diabetes: unpredictable hypo- \& hyperglycemia. Severe cardiovascular autonomic or peripheral neuropathy (guidelines.diabetes.ca/cpg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ottawa

Ottawa, Ontario, K1N6N5, Canada

Location

MeSH Terms

Conditions

HyperthermiaHypertensionHeat Stress Disorders

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsWounds and InjuriesVascular DiseasesCardiovascular Diseases

Study Officials

  • Glen P Kenny, PhD

    University of Ottawa

    PRINCIPAL INVESTIGATOR
  • Ronald J Sigal, MD, MPH

    University of Calgary

    PRINCIPAL INVESTIGATOR
  • Robert D Meade, PhD

    University of Ottawa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Glen P Kenny, PhD

CONTACT

Robert D Meade, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will be informed of the study interventions before providing informed consent but will be blinded to the specific trial condition at each of the 3 laboratory visits (control, recommended cooling, hybrid cooling). Data will be blinded prior to analysis.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participant will complete 3 simulated extreme heat event exposures in random order: i) no cooling center intervention (control); ii) recommended cooling center intervention (1 x 2-hours of brief air-conditioning); and iii) hybrid cooling center intervention (2 x 1-hour interspersed brief air-conditioning)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor, University Research Chair

Study Record Dates

First Submitted

February 25, 2022

First Posted

March 10, 2022

Study Start

May 1, 2023

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

October 21, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

Deidentified participant data will be available from Dr. Kenny upon reasonable request and signed access agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
After study completion
Access Criteria
Reasonable request and signed access agreement

Locations